Immunohistochemistry analysis of the tumors derived either from the parental MDA-MB-231 cells or from the WAVE3 knockdown cells in the subcutaneous model. A: Staining for the WAVE3 protein in the lung tumors from wild-type MDA-MB-231 cells show high levels of WAVE3 protein (a, b), compared with one of the rare lung metastases from cells expressing shWAVE3 (c, d), which shows marked reduction in WAVE3 levels, although some immunoreactivity is still seen. B: IgG staining as a negative control for the WAVE3 antibody in tumors from parental MDA-MB-231 (a, b) and of tumors from cells expressing shWAVE3 (c, d). C: Immunostaining for VEGF shows higher immunoreactivity in the MDA-MB-231-derived tumor (a), compared with the tumors derived from the WAVE knockdown cells (b). D: Immunostaining for CD31 demonstrates relatively large numbers of blood vessels and abnormal tumor vasculature in the MDA-MB-231-derived tumors (a), whereas fewer and more regular-shaped blood vessels are seen the WAVE knockdown-derived tumors (b). E: Microvessel density within tumor sections was determined in five fields of each tumor section, and presented as the mean number of microvessels per field. Original magnifications: ×100 (Aa, Ac, Bb, Bd); ×400 (Ab, Ad, E); ×40 (Ba, Bc).